Subgenotypes and mutations in the s and polymerase genes of hepatitis b virus carriers in the west bank, palestine

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Abdelnabi, Zakeih ^a   Saleh, Niveen ^a   Baraghithi, Sabri ^b   Glebe, Dieter ^c   Azzeh, Maysa ^a  

^a AL QUDS UNIVERSITY   (Palestine)

^b Mount of Olives   (Palestine)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; RNA DIRECTED DNA POLYMERASE;

ADOLESCENT; AGED; ARTICLE; CHILD; DRUG RESISTANCE; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS B VIRUS GENOTYPE D; HUMAN; INFANT; MALE; NONHUMAN; PALESTINE; S GENE; STRUCTURAL GENE; VIRUS CARRIER; VIRUS DETECTION; VIRUS GENE; VIRUS GENOME; VIRUS ISOLATION; VIRUS LOAD; VIRUS STRAIN; ADULT; BLOOD; CLASSIFICATION; GENETICS; HEPATITIS B; ISOLATION AND PURIFICATION; MIDDLE AGED; MIDDLE EAST; MOLECULAR GENETICS; MUTATION; PRESCHOOL CHILD; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

HEPATITIS B VIRUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; GENES, VIRAL; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; INFANT; MALE; MIDDLE AGED; MIDDLE EAST; MOLECULAR SEQUENCE DATA; MUTATION; RNA-DIRECTED DNA POLYMERASE; YOUNG ADULT;

EID: 84917710519     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113821     Document Type: Article

References (74)

1. Ott JJ, Stevens GA, Groeger J, Wiersma ST (2012) Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 30: 2212-2219.
2. Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, et al. (2004) Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47: 289-309.
3. Kramvis A (2014) Genotypes and genetic variability of hepatitis B virus Intervirology 57: 141-150.
4. Ma Y, Ding Y, Juan F, Dou XG (2011) Genotyping the hepatitis B virus with a fragment of the HBV DNA polymerase gene in Shenyang, China. Virology journal 8: 315.
5. Courouce-Pauty AM, Soulier JP (1974) Further data on HBs antigen subtypes - geographical distribution. Vox sanguinis 27: 533-549.
6. Brown SE, Howard CR, Zuckerman AJ, Steward MW (1984) Affinity of antibody responses in man to hepatitis B vaccine determined with synthetic peptides. Lancet 2: 184-187.
7. Guerrero E, Swenson PD, Hu PS, Peterson DL (1990) The antigenic structure of HBsAg: study of the d/y subtype determinant by chemical modification and site directed mutagenesis. Molecular immunology 27: 435-441.
8. Howard CR, Stirk H, Brown SE, Steward MW (1988) Towards the development of synthetic hepatitis B vaccines. Viral Hepatitis and Liver Disease: 1094-1101.
9. Gunther S, Fischer L, Pult I, Sterneck M, Will H (1999) Naturally occurring variants of hepatitis B virus. Advances in virus research. 1999/06/29 ed: Academic Press. pp.25-137.
10. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, et al. (1990) Vaccine-induced escape mutant of hepatitis B virus. Lancet 336: 325-329.
11. Hino K, Okuda M, Hashimoto O, Ishiko H, Okazaki M, et al. (1995) Glycine-to-arginine substitution at codon 145 of HBsAg in two infants born to hepatitis B e antigen-positive carrier. Digestive diseases and sciences 40: 566-570.
12. Karthigesu VD, Allison LM, Fortuin M, Mendy M, Whittle HC, et al. (1994) A novel hepatitis B virus variant in the sera of immunized children. The Journal of general virology 75 (Pt2): 443-448.
13. Ghany M, Liang TJ (2007) Drug targets and molecular mechanisms of drug resistance in chronic hepatitis B. Gastroenterology 132: 1574-1585.
14. Gojobori T, Moriyama EN, Kimura M (1990) Molecular clock of viral evolution, and the neutral theory. Proceedings of the National Academy of Sciences of the United States of America 87: 10015-10018.
15. Locarinin S (2004) Molecular Virology of Hepatitis B Virus. Molecular Virology 24: 03-10.
16. Lai CL, Dienstag J, Schiff E, Leung NW, Atkins M, et al. (2003) Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 36: 687-696.
17. Yu JW, Sun LJ, Yan BZ, Kang P, Zhao YH (2011) Lamivudine treatment is associated with improved survival in fulminant hepatitis B. Liver international: official journal of the International Association for the Study of the Liver 31: 499-506.
18. Stramer SL, Wend U, Candotti D, Foster GA, Hollinger FB, et al. (2011) Nucleic acid testing to detect HBV infection in blood donors. The New England journal of medicine 364: 236-247.
19. Jursch CA, Gerlich WH, Glebe D, Schaefer S, Marie O, et al. (2002) Molecular approaches to validate disinfectants against human hepatitis B virus. Medical microbiology and immunology 190: 189-197.
20. Khaled IA, Mahmoud OM, Saleh AF, Bioumie EE (2011) Prevalence of HBV genotypes among Egyptian hepatitis patients. Molecular biology reports 38: 4353-4357.
21. Zekri AR, Hafez MM, Mohamed NI, Hassan ZK, El-Sayed MH, et al. (2007) Hepatitis B virus (HBV) genotypes in Egyptian pediatric cancer patients with acute and chronic active HBV infection. Virology journal 4: 74.
22. Masaadeh HA, Hayajneh WA, Alqudah EA (2008) Hepatitis B virus genotypes and lamivudine resistance mutations in Jordan. World journal of gastroenterology: WJG 14: 7231-7234.
23. Ben-Ari Z, Mor E, Bar-Nathan N, Shaharabani E, Shapira Z, et al. (2003) Combination hepatitis B immune globulin and lamivudine versus hepatitis B immune globulin monotherapy in preventing recurrent hepatitis B virus infection in liver transplant recipients. Transplantation proceedings 35: 609-611.
24. Antaki N, Haffar S, Ali Deeb S, Assaad F, Abou Harb R, et al. (2010) High prevalence of HBV genotype D in Syria and the clinical characteristics of hepatitis B e antigen-negative chronic hepatitis B. Epidemiology and infection138: 40-44.
25. El Chaar M, El Jisr T, Allain JP (2012) Hepatitis B virus DNA splicing in Lebanese blood donors and genotype A to E strains: implications for hepatitis B virus DNA quantification and infectivity. Journal of clinical microbiology 50: 3159-3167.
26. Cox LE, Arslan O, Allain JP (2011) Characterization of hepatitis B virus in Turkish blood donors, and the prevalence of the SP1 splice variant. Journal of medical virology 83: 1321-1325.
27. Sayan M, Dogan C (2012) Genotype/subgenotype distribution of hepatitis B virus among hemodialysis patients with chronical hepatitis B. Annals of hepatology11: 849-854.
28. Fylaktou A, Papaventsis D, Daoudaki M, Moskophidis M, Reiberger T, et al. (2011) Molecular epidemiology of chronic hepatitis B virus infection in Greece. Journal of medical virology 83: 245-252.
29. Garmiri P, Rezvan H, Abolghasemi H, Allain JP (2011) Full genome characterization of hepatitis B virus strains from blood donors in Iran. Journal of medical virology 83: 948-952.
30. Baig S, Siddiqui A, Chakravarty R, Moatter T (2009) Hepatitis B virus subgenotypes D1 and D3 are prevalent in Pakistan. BMC research notes 2: 1.
31. Ragheb M, Elkady A, Tanaka Y, Murakami S, Attia FM, et al. (2012) Multiple intra-familial transmission patterns of hepatitis B virus genotype D in north-eastern Egypt. Journal of medical virology 84: 587-595.
32. Hanada K, Shiu SH, Li WH (2007) The nonsynonymous/synonymous substitution rate ratio versus the radical/conservative replacement rate ratio in the evolution of mammalian genes. Molecular biology and evolution 24: 2235-2241.
33. Ghany MG, Ayola B, Villamil FG, Gish RG, Rojter S, et al. (1998) Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. Hepatology 27: 213-222.
34. Weinberger KM, Bauer T, Bohm S, Jilg W (2000) High genetic variability of the group-specific adeterminant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. The Journal of general virology 81: 1165-1174.
35. Komatsu H, Inui A, Sogo T, Konishi Y, Tateno A, et al. (2012) Hepatitis B surface gene 145 mutant as a minor population in hepatitis B virus carriers. BMC research notes 5: 22.
36. Mele A, Tancredi F, Romano L, Giuseppone A, Colucci M, et al. (2001) Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen-positive mothers in Italy. The Journal of infectious diseases 184: 905-908.
37. Torresi J, Earnest-Silveira L, Deliyannis G, Edgtton K, Zhuang H, et al. (2002) Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapy. Virology 293: 305-313.
38. Zuckerman JN, Zuckerman AJ (2003) Mutations of the surface protein of hepatitis B virus. Antiviral research 60: 75-78.
39. Allain JP, Mihaljevic I, Gonzalez-Fraile MI, Gubbe K, Holm-Harritshoj L, et al. (2013) Infectivity of blood products from donors with occult hepatitis B virus infection. Transfusion 53: 1405-1415.
40. Gerlich WH, Bremer C, Saniewski M, Schuttler CG, Wend UC, et al. (2010) Occult hepatitis B virus infection: detection and significance. Digestive diseases 28: 116-125.
41. Lee JM, Ahn SH (2011) Quantification of HBsAg: basic virology for clinical practice. World journal of gastroenterology: WJG 17: 283-289.
42. Weber B (2005) Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact. Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology 32: 102-112.
43. Chang MH (2010) Breakthrough HBV infection in vaccinated children in Taiwan: surveillance for HBV mutants. Antiviral therapy 15: 463-469.
44. Locarnini SA, Yuen L (2010) Molecular genesis of drug-resistant and vaccine-escape HBV mutants. Antiviral therapy 15: 451-461.
45. Hannoun C, Horal P, Lindh M (2000) Long-term mutation rates in the hepatitis B virus genome. The Journal of general virology 81: 75-83.
46. Mathet VL, Cuestas ML, Ruiz V, Minassian ML, Rivero C, et al. (2006) Unusual naturally occurring humoral and cellular mutated epitopes of hepatitis B virus in a chronically infected argentine patient with anti-HBs antibodies. Journal of clinical microbiology 44: 2191-2198.
47. Mathet VL, Cuestas ML, Ruiz V, Minassian ML, Rivero C, et al. (2006) Detection of hepatitis B virus (HBV) genotype E carried-even in the presence of high titers of anti-HBs antibodies-by an Argentinean patient of African descent who had received vaccination against HBV. Journal of clinical microbiology 44: 3435-3439.
48. Stevens CE, Beasley RP, Tsui J, Lee WC (1975) Vertical transmission of hepatitis B antigen in Taiwan. The New England journal of medicine 292: 771-774.
49. Okada K, Kamiyama I, Inomata M, Imai M, Miyakawa Y (1976) e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. The New England journal of medicine 294: 746-749.
50. Beasley RP, Trepo C, Stevens CE, Szmuness W (1977) The e antigen and vertical transmission of hepatitis B surface antigen. American journal of epidemiology 105: 94-98.
51. Beasley RP, Hwang LY, Lee GC, Lan CC, Roan CH, et al. (1983) Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 2: 1099-1102.
52. Burk RD, Hwang LY, Ho GY, Shafritz DA, Beasley RP (1994) Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load. The Journal of infectious diseases 170: 1418-1423.
53. Chang MH (2007) Hepatitis B virus infection. Seminars in fetal & neonatal medicine 12: 160-167.
54. Lee C, Gong Y, Brok J, Boxall EH, Gluud C (2006) Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. BMJ 332: 328-336.
55. Plitt SS, Somily AM, Singh AE (2007) Outcomes from a Canadian public health prenatal screening program for hepatitis B: 1997-2004. Canadian journal of public health 5 Revue canadienne de sante publique 98: 194-197.
56. Spada E, Tosti ME, Zuccaro O, Stroffolini T, Mele A (2011) Evaluation of the compliance with the protocol for preventing perinatal hepatitis B infection in Italy. The Journal of infection 62: 165-171.
57. McMahon BJ, Bulkow LR, Singleton RJ, Williams J, Snowball M, et al. (2011) Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization program. Hepatology 54: 801-807.
58. Harder KM, Cowan S, Eriksen MB, Krarup HB, Christensen PB (2011) Universal screening for hepatitis B among pregnant women led to 96% vaccination coverage among newborns of HBsAg positive mothers in Denmark. Vaccine 29: 9303-9307.
59. Hu Y, Zhang S, Luo C, Liu Q, Zhou YH (2012) Gaps in the prevention of perinatal transmission of hepatitis B virus between recommendations and routine practices in a highly endemic region: a provincial population-based study in China. BMC infectious diseases 12: 221.
60. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP (2006) Hepatitis B virus infection: epidemiology and vaccination. Epidemiologic reviews 28: 112-125.
61. Ni YH, Huang LM, Chang MH, Yen CJ, Lu CY, et al. (2007) Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies. Gastroenterology 132: 1287-1293.
62. Willis BC, Wortley P, Wang SA, Jacques-Carroll L, Zhang F (2010) Gaps in hospital policies and practices to prevent perinatal transmission of hepatitis B virus. Pediatrics 125: 704-711.
63. Norouzi M, Ghorashi S, Abedi F, Nejatizadeh A, Ataei B, et al. (2012) Identification of Hepatitis B Virus Surface Antigen (HBsAg) Genotypes and Variations in Chronic Carriers from Isfahan Province, Iran. Iranian journal of public health 41: 104-111.
64. Kim JH, Jung YK, Joo MK, Yim HJ, Park JJ, et al. (2010) Hepatitis B viral surface mutations in patients with adefovir resistant chronic hepatitis B with A181T/V polymerase mutations. Journal of Korean medical science 25: 257-264.
65. Olinger CM, Weber B, Otegbayo JA, Ammerlaan W, van der Taelem-Brule N, et al. (2007) Hepatitis B virus genotype E surface antigen detection with different immunoassays and diagnostic impact of mutations in the preS/S gene. Medical microbiology and immunology 196: 247-252.
66. Araujo NM, Vianna CO, Moraes MT, Gomes SA (2009) Expression of Hepatitis B virus surface antigen (HBsAg) from genotypes A, D and F and influence of amino acid variations related or not to genotypes on HBsAg detection. The Brazilian journal of infectious diseases: an official publication of the Brazilian Society of Infectious Diseases 13: 266-271.
67. Geretti AM, Patel M, Sarfo FS, Chadwick D, Verheyen J, et al. (2010) Detection of highly prevalent hepatitis B virus coinfection among HIV-seropositive persons in Ghana. Journal of clinical microbiology 48: 3223-3230.
68. Margeridon-Thermet S, Shulman NS, Ahmed A, Shahriar R, Liu T, et al. (2009) Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patients. The Journal of infectious diseases 199: 1275-1285.
69. Colonno RJ, Rose R, Baldick CJ, Levine S, Pokornowski K, et al. (2006) Entecavir resistance is rare in nucleoside naive patients with hepatitis B. Hepatology44: 1656-1665.
70. Katsoulidou A, Paraskevis D, Magiorkinis E, Moschidis Z, Haida C, et al. (2009) Molecular characterization of occult hepatitis B cases in Greek blood donors. Journal of medical virology 81: 815-825.
71. Geipel A (2011) Phä notypische Charakterisierung klinisch relevanter Hepatitis-B-Virus-Mutanten: university Gieβen.
72. Costantini A, Marinelli K, Biagioni G, Monachetti A, Ferreri ML, et al. (2011) Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy. BMC infectious diseases 11: 310.
73. Pollicino T, Isgro G, Di Stefano R, Ferraro D, Maimone S, et al. (2009) Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudineresistant chronic hepatitis B patients. Antiviral therapy 14: 649-654.
74. Wu Y, Gan Y, Gao F, Zhao Z, Jin Y, et al. (2014) Novel natural mutations in the hepatitis B virus reverse transcriptase domain associated with hepatocellular carcinoma. PloS one 9: e94864.